FOLD - Amicus Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.38B
Enterprise Value 32.82B
Trailing P/E N/A
Forward P/E 1-13.12
PEG Ratio (5 yr expected) 1-0.05
Price/Sales (ttm)31.11
Price/Book (mrq)6.75
Enterprise Value/Revenue 325.99
Enterprise Value/EBITDA 6-8.16

Trading Information

Stock Price History

Beta (3Y Monthly) 1.70
52-Week Change 3-20.69%
S&P500 52-Week Change 36.52%
52 Week High 316.27
52 Week Low 38.27
50-Day Moving Average 312.05
200-Day Moving Average 312.43

Share Statistics

Avg Vol (3 month) 32.91M
Avg Vol (10 day) 33.02M
Shares Outstanding 5142.69M
Float 190.96M
% Held by Insiders 11.08%
% Held by Institutions 1104.95%
Shares Short (Jun 28, 2019) 424.67M
Short Ratio (Jun 28, 2019) 47.43
Short % of Float (Jun 28, 2019) 410.75%
Short % of Shares Outstanding (Jun 28, 2019) 49.70%
Shares Short (prior month May 31, 2019) 417.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-322.57%

Management Effectiveness

Return on Assets (ttm)-26.79%
Return on Equity (ttm)-86.18%

Income Statement

Revenue (ttm)108.59M
Revenue Per Share (ttm)0.56
Quarterly Revenue Growth (yoy)103.90%
Gross Profit (ttm)76.84M
EBITDA -346.05M
Net Income Avi to Common (ttm)-419.38M
Diluted EPS (ttm)-2.15
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)438.33M
Total Cash Per Share (mrq)1.9
Total Debt (mrq)207.44M
Total Debt/Equity (mrq)45.93
Current Ratio (mrq)7.33
Book Value Per Share (mrq)1.96

Cash Flow Statement

Operating Cash Flow (ttm)-328.98M
Levered Free Cash Flow (ttm)-286.37M